U K Rinne, V Sonninen, T Siirtola. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Age FactorsAnorexia Nervosa/chemically inducedCardiovascular Diseases/chemically inducedClinical Trials as TopicDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/therapeutic useDopamine/metabolismDrug SynergismFemaleHumansHypotension/chemically inducedLibidoMaleMenstruationMental Disorders/chemically inducedMiddle AgedMovement Disorders/chemically inducedNausea/chemically inducedParasympatholytics/therapeutic useParkinson Disease/bloodParkinson Disease/cerebrospinal fluidParkinson Disease/drug therapyParkinson Disease/metabolismPhenylacetates/cerebrospinal fluidVomiting/chemically induced
Substances: See more » ParasympatholyticsPhenylacetatesDihydroxyphenylalanineDopamine
Year: 1970 PMID: 4932969 DOI: 10.1159/000113990
Source DB: PubMed Journal: Eur Neurol ISSN: 0014-3022 Impact factor: 1.710